drugset / Trial / NCT02109185

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

NCT02109185

Phase 1 Completed 1307 enrolled Mylan Pharmaceuticals Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

The study will compare the safety and efficacy of a generic mometasone nasal spray to the reference listed drugs in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations will be tested for superiority against a placebo nasal spray.

Timeline

Start
2013-09
Primary completion
2013-10
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mometasone furoate Other / unclassified 50 ug Intranasal